Zu S, Lu Y, Xing R, Chen X, Zhang L
Sci Rep. 2024; 14(1):12188.
PMID: 38806640
PMC: 11133342.
DOI: 10.1038/s41598-024-63103-x.
Chung D, Ghaedi M, Warner K, Sayad A, Saibil S, Bernardini M
Oncoimmunology. 2024; 13(1):2349347.
PMID: 38746870
PMC: 11093043.
DOI: 10.1080/2162402X.2024.2349347.
Lynce F, Mainor C, Donahue R, Geng X, Jones G, Schlam I
Nat Commun. 2024; 15(1):2691.
PMID: 38538574
PMC: 10973408.
DOI: 10.1038/s41467-024-46961-x.
Ustiuzhanina M, Streltsova M, Timofeev N, Kryukov M, Chudakov D, Kovalenko E
Cells. 2024; 13(6.
PMID: 38534374
PMC: 10969127.
DOI: 10.3390/cells13060530.
Weber S, Menees K, Park J, Agin-Liebes J, Lin C, Alcalay R
NPJ Parkinsons Dis. 2024; 10(1):36.
PMID: 38360903
PMC: 10869354.
DOI: 10.1038/s41531-024-00652-y.
Systemic immune response in young and elderly patients after traumatic brain injury.
Magatti M, Pischiutta F, Ortolano F, Pasotti A, Caruso E, Cargnoni A
Immun Ageing. 2023; 20(1):41.
PMID: 37573338
PMC: 10422735.
DOI: 10.1186/s12979-023-00369-1.
Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes.
Kazemi M, Shokrollahi Barough M, Momeni-Varposhti Z, Ghanavatinejad A, Zarehzadeh Mehrabadi A, Sadeghi B
Med Oncol. 2023; 40(6):168.
PMID: 37149505
PMC: 10164001.
DOI: 10.1007/s12032-023-02034-5.
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.
Azoulay T, Slouzky I, Karmona M, Filatov M, Hayun M, Ofran Y
Cancer Immunol Immunother. 2022; 72(3):707-718.
PMID: 36048214
PMC: 10992952.
DOI: 10.1007/s00262-022-03284-4.
Fc-Mediated Functions of Porcine IgG Subclasses.
Paudyal B, Mwangi W, Rijal P, Schwartz J, Noble A, Shaw A
Front Immunol. 2022; 13:903755.
PMID: 35757698
PMC: 9218351.
DOI: 10.3389/fimmu.2022.903755.
Natural killer cells and acute myeloid leukemia: promises and challenges.
Rahmani S, Yazdanpanah N, Rezaei N
Cancer Immunol Immunother. 2022; 71(12):2849-2867.
PMID: 35639116
PMC: 10991240.
DOI: 10.1007/s00262-022-03217-1.
New Insights and Implications of Natural Killer Cells in Parkinson's Disease.
Menees K, Lee J
J Parkinsons Dis. 2022; 12(s1):S83-S92.
PMID: 35570499
PMC: 9535577.
DOI: 10.3233/JPD-223212.
Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions.
Brauning A, Rae M, Zhu G, Fulton E, Admasu T, Stolzing A
Cells. 2022; 11(6).
PMID: 35326467
PMC: 8947539.
DOI: 10.3390/cells11061017.
Enhanced co-culture and enrichment of human natural killer cells for the selective clearance of senescent cells.
Kim K, Admasu T, Stolzing A, Sharma A
Aging (Albany NY). 2022; 14(5):2131-2147.
PMID: 35245208
PMC: 8954966.
DOI: 10.18632/aging.203931.
Expansion of CD56CD16 NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.
Casado J, Moraga E, Vizcarra P, Velasco H, Martin-Hondarza A, Haemmerle J
Viruses. 2022; 14(1).
PMID: 35062250
PMC: 8780522.
DOI: 10.3390/v14010046.
The Dual Role of Innate Lymphoid and Natural Killer Cells in Cancer. from Phenotype to Single-Cell Transcriptomics, Functions and Clinical Uses.
Roma S, Carpen L, Raveane A, Bertolini F
Cancers (Basel). 2021; 13(20).
PMID: 34680190
PMC: 8533946.
DOI: 10.3390/cancers13205042.
Peptide Adjuvant to Invigorate Cytolytic Activity of NK Cells in an Obese Mouse Cancer Model.
Han S, Jung M, Kim A, Lee D, Cha B, Putnam C
Pharmaceutics. 2021; 13(8).
PMID: 34452238
PMC: 8401452.
DOI: 10.3390/pharmaceutics13081279.
Abnormality in the NK-cell population is prolonged in severe COVID-19 patients.
Leem G, Cheon S, Lee H, Choi S, Jeong S, Kim E
J Allergy Clin Immunol. 2021; 148(4):996-1006.e18.
PMID: 34339730
PMC: 8324384.
DOI: 10.1016/j.jaci.2021.07.022.
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.
Gomez-Munoz L, Perna-Barrull D, Villalba A, Rodriguez-Fernandez S, Ampudia R, Teniente-Serra A
Front Immunol. 2021; 11:611522.
PMID: 33569058
PMC: 7869615.
DOI: 10.3389/fimmu.2020.611522.
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.
Solorzano-Ibarra F, Alejandre-Gonzalez A, Ortiz-Lazareno P, Bastidas-Ramirez B, Zepeda-Moreno A, Tellez-Banuelos M
Clin Exp Immunol. 2020; 204(1):78-95.
PMID: 33306195
PMC: 7944364.
DOI: 10.1111/cei.13561.
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia.
Makanga D, Da Rin de Lorenzo F, David G, Willem C, Dubreuil L, Legrand N
Cancers (Basel). 2020; 12(7).
PMID: 32708751
PMC: 7409189.
DOI: 10.3390/cancers12071927.